Medical Properties Trust, Inc. (MPT)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $983.46M
Last updated: Nov 17, 2026 at 11:06 AM ET
Medical Properties Trust, Inc. (MPT) Financials: Revenue, Profit and Cash Flow
Medical Properties Trust reported revenue of $972.02M for the fiscal year ended Dec 31, 2025, down 2.4% from the year before. That year, net income was -$277.05M with a net margin of -28.5%, operating cash flow was $230.77M and free cash flow was $8.68M. The quarter ended Sep 30, 2026 had revenue of $250.14M and net income of $201.58M.
Revenue and Margins
The operating margin was 55.5% in the fiscal year ended Dec 2025. Over the 10 years to Dec 2025, revenue grew from $441.88M, a compound annual rate of 8.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $972.02M | -2.4% | 96.3% | 55.5% | -28.5% |
| Dec 2024 | $995.55M | +14.2% | 97.3% | 38.9% | -242.1% |
| Dec 2023 | $871.80M | -43.5% | 95.2% | 9.3% | -63.8% |
| Dec 2022 | $1.54B | -0.1% | 97.0% | 65.1% | 58.5% |
| Dec 2021 | $1.54B | +23.6% | 97.5% | 67.2% | 42.5% |
| Dec 2020 | $1.25B | +43.5% | 98.0% | N/A | 34.5% |
| Dec 2019 | $870.25M | N/A | 97.2% | 86.2% | 43.1% |
| Dec 2017 | $704.75M | +30.2% | 99.2% | 68.9% | 41.1% |
| Dec 2016 | $541.14M | +22.5% | 99.5% | 63.1% | 41.6% |
| Dec 2015 | $441.88M | N/A | 99.1% | 59.6% | 31.6% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $972.02M | $995.55M | $871.80M | $1.54B | $1.54B | $1.25B | $870.25M | $704.75M | $541.14M | $441.88M |
| Cost of revenue | $36.41M | $27.25M | $41.57M | $45.70M | $39.10M | $24.89M | $23.99M | $5.81M | $2.71M | $3.79M |
| Gross profit | $935.61M | $968.29M | $830.23M | $1.50B | $1.51B | $1.22B | $846.26M | $698.93M | $538.42M | $438.09M |
| Operating income | $539.77M | $386.85M | $81.28M | $1.00B | $1.04B | N/A | $749.85M | $485.58M | $341.64M | $263.24M |
| Net income | -$277.05M | -$2.41B | -$556.48M | $902.60M | $656.02M | $431.45M | $374.68M | $289.79M | $225.05M | $139.60M |
| EBITDA | $545.86M | N/A | $340.24M | $1.67B | $1.46B | $1.10B | $754.11M | $647.21M | $476.31M | $334.14M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $250.14M | $259.28M | $252.06M | $270.34M | $237.52M | $240.36M | $223.80M | $235.27M | $225.83M | $266.56M | $271.32M | -$122.38M |
| Gross profit | $238.74M | $109.17M | $242.13M | $260.82M | $228.53M | $229.50M | $216.76M | $225.49M | $220.83M | $258.90M | $266.50M | -$125.68M |
| Operating income | $115.49M | $143.86M | $140.20M | $169.11M | $123.80M | $136.58M | $110.28M | $197.00M | -$20.67M | $121.33M | $157.56M | -$233.13M |
| Net income | $201.58M | -$2.60M | $32.83M | $17.31M | -$77.73M | -$98.36M | -$118.28M | -$412.85M | -$801.16M | -$320.63M | -$875.63M | -$663.94M |
Balance Sheet
As of Dec 2025, total debt of $10.34B exceeded cash and equivalents by $9.80B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.00B | $14.29B | $18.30B | $19.66B | $20.52B | $16.83B | $14.47B | $9.02B | $6.42B | $5.61B |
| Current assets | $1.82B | $1.31B | $1.40B | $1.72B | $4.55B | $4.04B | $4.51B | $436.03M | $257.80M | $324.63M |
| Cash and equivalents | $540.86M | $332.33M | $250.02M | $235.67M | $459.23M | $549.88M | $1.46B | $171.47M | $83.24M | $195.54M |
| Total liabilities | $10.39B | $9.46B | $10.67B | $11.06B | $12.07B | $9.49B | $7.44B | $5.19B | $3.17B | $3.50B |
| Short-term debt | $638.06M | $361.73M | $1.51B | $929.58M | $4.20M | $51.30M | $5.60M | N/A | $320.00K | $125.30M |
| Long-term debt | $9.70B | $8.49B | $8.55B | $9.34B | $9.68B | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $4.61B | $4.83B | $7.63B | $8.59B | $8.44B | $7.34B | $7.03B | $3.82B | $3.25B | $2.10B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.39B | $14.75B | $14.76B | $15.00B | $14.92B | $15.15B | $14.85B | $14.29B | $15.24B | $16.19B | $17.30B | $18.30B |
| Total liabilities | $9.77B | $10.25B | $10.22B | $10.39B | $10.26B | $10.32B | $10.09B | $9.46B | $9.80B | $10.00B | $10.60B | $10.67B |
| Cash and equivalents | $599.28M | $396.56M | $425.00M | $540.86M | $396.58M | $509.83M | $673.48M | $332.33M | $275.62M | $606.55M | $224.34M | $250.02M |
| Shareholder equity | $4.62B | $4.50B | $4.54B | $4.61B | $4.66B | $4.83B | $4.76B | $4.83B | $5.44B | $6.19B | $6.70B | $7.63B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 3.8% of operating cash flow. Dividends came to 2226.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $230.77M | $245.48M | $505.79M | $739.01M | $811.66M | $617.64M | $494.12M | $363.10M | $264.68M | $207.00M |
| Capital expenditures | $222.09M | $185.41M | $349.61M | $1.54B | $65.55M | $4.29B | $4.86B | $2.25B | $27.56M | $2.22B |
| Free cash flow | $8.68M | $60.08M | $156.17M | -$801.35M | $746.11M | -$3.67B | -$4.36B | -$1.88B | $237.13M | -$2.01B |
| Dividends paid | $193.26M | $321.08M | $615.39M | $698.53M | $643.47M | $567.97M | $411.70M | $326.73M | $218.39M | $182.98M |
| Investing cash flow | -$264.74M | $1.32B | $517.56M | $396.06M | -$3.86B | -$2.95B | -$4.88B | -$2.36B | -$926.54M | -$1.95B |
| Financing cash flow | $228.08M | -$1.48B | -$1.02B | -$1.34B | $2.95B | $1.40B | $5.04B | $2.07B | $552.56M | $1.80B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $41.14M | $62.44M | -$14.26M | $160.06M | $18.57M | $51.75M | $384.00K | $76.69M | $59.20M | $35.26M | $74.34M | $135.42M |
| Capital expenditures | $0 | $0 | $0 | $222.09M | $170.84M | $142.95M | $65.37M | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | $41.14M | $62.44M | -$14.26M | -$62.03M | -$152.26M | -$91.20M | -$64.98M | $76.69M | $59.20M | $35.26M | $74.34M | $135.42M |
Frequently Asked Questions About MPT
What is Medical Properties Trust's annual revenue?
Medical Properties Trust reported revenue of $972.02M for the fiscal year ended Dec 31, 2025.
How fast is Medical Properties Trust's revenue growing?
Revenue was down 2.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -14.3%.
Is Medical Properties Trust profitable?
No. Medical Properties Trust reported net income of -$277.05M for the fiscal year ended Dec 31, 2025, with a net margin of -28.5%.
How much free cash flow does MPT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $230.77M minus capital expenditures of $222.09M produced free cash flow of $8.68M.
How much debt does Medical Properties Trust have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $9.70B, short-term debt of $638.06M and cash and equivalents of $540.86M.
MPT pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors